Terray raised $120 million to advance AI-driven drug discovery
Longevity Technology - 21-Oct-2024Their partnership with Calico focuses on age-related disease treatments
Join the club for FREE to access the whole archive and other member benefits.
Combating aging and associated diseases. An Alphabet (Google) subsidiary.
Founded in 2013 by Bill Maris.
Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
Chief scientist, David Botstein, retired late 2022.
Visit website: https://www.calicolabs.com/
Details last updated 04-Feb-2019
Global dynamic model of transcriptional regulation in budding yeast
Their partnership with Calico focuses on age-related disease treatments
ABBV-CLS-484 enhances anti-tumor immunity and is currently in clinical trials
Selectively inhibits problematic free radicals - potential breakthrough in treatment of chronic diseases & ageing
Terray’s novel microarray technology, combines wet lab and computer-driven drug development
Supports ageing research and advancing early-stage projects to phase 2 trials over the next decade
Possible ways of using reprogramming techniques to develop therapies
More and more companies making greater and greater progress - 2021 could be an exciting year
Clinical trials in progress for potential targets of cancer and neurodegenerative diseases
An experimental drug restores age related memory loss and brain function in mice
Ex-Genentech CEO's drug company starts first clinical trial of cancer research
Will be presenting a viable therapeutic strategy using IGF signaling at ARDD 2020
Calico creator is now investing on frontier technology, healthcare & lifescience
Made possible by Calico's research expertise and Google AI's machine learning tech
Family tree data suggests hereditary genes contributed to no more than 7% of a person's lifespan
High cell damage tolerance, unfaltering telomeres, stem cells, to mention a few
Possible hints where they are focusing their research
Billionaires are now pouring millions into longevity research. Upgrading the human immune system...
Insilico Medicine applying big data analytics to extend healthy longevity. pursuing internal dru...
Zoltan Istvan reports from RAAD Fest – the biggest life extension festival in history. 1000 atte...
They will not be old in mind or body, only in years. Likely to amplify economic inequality. Tho...
Gains in US life expectancy mostly benefiting those with higher income. Income is the single big...
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.
Google CEO Larry Page discusses the launch of Calico. Will focus on health and aging in particul...